Phase 2
-
Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC
Phase 2 · 60 people · 1 site in Singapore · Recruiting now
-
A Phase II Randomized Trial of Serplulimab With Second-Line Chemo/Targeted Therapy for Early Relapse Colorectal Cancer After Adjuvant Chemotherapy
Phase 2 · randomised · 40 people · 1 site in China · Recruiting now
-
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Phase 2 · 754 people · 21 sites in United States · Recruiting now
-
Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors
Phase 2 · 212 people · 10 sites in United States · Recruiting now
-
Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gastrointestinal Solid Tumors
Phase 2 · randomised · 220 people · 1 site in China · Recruiting now
-
A Phase I-II Study to Test the Safety and Efficacy of PD1 (AB122) and Adenosine Receptor (AB928) Antagonists With Chemotherapy After Short-Course Radiation for Rectal Cancer.
Phase 2 · 43 people · 3 sites in United States · Recruiting now
-
Single Arm Study of Neoadjuvant Dostarlimab in Stage II and III Deficient Mismatch Repair Colon Cancers
Phase 2 · 25 people · 2 sites in United States · Recruiting now